Leprosy Cases In Morocco Show a Decrease After Implementation Of Rifampicin Regimen as a preventative measure. Since 2012, the number of cases of leprosy in Morocco has declined by more than 16 percent per year. The results of this study are published in the journal of PLOS Neglected Tropical Diseases.
Leprosy is a chronic infectious disease, affecting mainly the skin and peripheral nerves, which can lead to severe disability. Since antibacterial multidrug therapy against leprosy was introduced in 1981, the number of cases of leprosy worldwide has plummeted.
Rifampicin: New Anti-Wolbachia Drug Regimen Changes Therapeutic Approach For Parasitic Helminth Diseases
Rifampicin antibiotic is a new anti-wolbachia drug that was found to change the therapeutic approach for parasitic helminth diseases.
Advertisement
‘To stop the spread of leprosy between household contacts, in 2012, Morocco introduced a program to administer Single Dose Rifampicin Chemoprophylaxis (SDRC). This measure was found to be very effective as after the implementation of SDRC the annual leprosy cases dropped to -16.83% per year.’
Tweet it Now
To fully interrupt transmission in countries such as Morocco, however, additional control efforts are needed. In 2012, Morocco introduced a program to administer Single Dose Rifampicin Chemoprophylaxis (SDRC) to stop the spread of leprosy between household contacts.
In the new work, Ibtissam Khoudri of Morocco's Ministry of Health and colleagues analyzed the leprosy cases detected in Morocco each year between 2000 and 2017. Data on leprosy patients--including age, gender, origin, region, and grade of disability--was included.
![New Naturally Occurring Antibiotic May Help Fight Against Drug-resistant Tuberculosis]( "New Naturally Occurring Antibiotic May Help Fight Against Drug-resistant Tuberculosis")
Kanglemycin A, a naturally occurring antibiotic found effective against Mycobacterium tuberculosis
Between 2000 and 2012, the annual percent change of leprosy cases was -4.68% per year. However, after the implementation of SDRC, between 2012 and 2017, the annual percent change was -16.83% per year.
In particular, the number of cases decreased more quickly after 2012 in men, children, ten specific regions, and in both urban and rural areas. During the last five years, an average of just 26 new cases per year were detected.
"This time series can be of interest for the medical community as the authors analyze the trends in leprosy in the last 17 years and try to generate a hypothesis about any relationship with chemoprophylaxis implementation," the researchers say.
Source: Eurekalert
New Naturally Occurring Antibiotic May Help Fight Against Drug-resistant Tuberculosis
Kanglemycin A, a naturally occurring antibiotic found effective against Mycobacterium tuberculosis
Advertisement
Between 2000 and 2012, the annual percent change of leprosy cases was -4.68% per year. However, after the implementation of SDRC, between 2012 and 2017, the annual percent change was -16.83% per year.
In particular, the number of cases decreased more quickly after 2012 in men, children, ten specific regions, and in both urban and rural areas. During the last five years, an average of just 26 new cases per year were detected.
"This time series can be of interest for the medical community as the authors analyze the trends in leprosy in the last 17 years and try to generate a hypothesis about any relationship with chemoprophylaxis implementation," the researchers say.
Source: Eurekalert
'Survival Gene' Suppresses Mutation Rates in Tuberculosis Bacteria
A key 'survival gene' that prevents strains of tuberculosis (TB) from mutating into drug-resistant 'superbugs' have been discovered.
Advertisement
Advertisement
|
Advertisement
Recommended Reading
Latest Research News
Brain plasticity following blindness leads to superior ability in sensing signals from the heart, which has implications for bodily awareness and emotional processing.
A group of scientists were awarded £1.3 million to create a new “point of care testing” kit that detects Alzheimer's disease biomarkers.
Is there a connection between Osteoporosis and dementia? Yes, loss in bone density may be linked to an increased risk of dementia in older age.
Link between chromosome length and biological aging marker discovered. The finding helps explain why people with longer telomeres have a lower dementia risk.
Integrated structural biology helps discover how the cystic fibrosis transmembrane conductance regulator (CFTR) works.